Thonningia sanguinea Vahl plays an important role in traditional medicine in many African cultures. A study of the n-hexane fraction of the whole plant of T. sanguinea led to the isolation of two glucocerebroside molecular species TSC-1 and TSC-2, one b-sitosteryl-3b-D-glucopyranoside-6 0 -O-fatty acid ester molecular species, TSS-1, and seven known triterpenes (1-7). The ethyl acetate fraction also afforded five known lignans (8-12) and one known flavanone (13). Their structures were elucidated by means of chemical and spectroscopic methods (methanolysis, NMR and mass spectrometry). Spectral analyses of the glucocerebrosides revealed mainly sphingosine-type (TSC-1) and phytosphingosine-type (TSC-2) cerebrosides, with both possessing mainly 2-hydroxy fatty acid and b-D-glucopyranose moieties. TSS-1 was found to be a b-sitosterol-type with fatty acid methyl esters and b-D-glucopyranoside moieties. The classes of compounds isolated from this plant are well known for their interesting biological activities including antimicrobial, antioxidant, anticancer, antiinflammatory and analgesic. They may therefore be responsible in part or in whole for these activities, hence validating the traditional uses of the plant. To the best of our knowledge, this is the first report on the isolation of all these compounds from T. sanguinea.
Introduction
Thonningia sanguinea Vahl is a owering plant in the monotypic genus Thonningia of the family Balanophoraceae. Synonyms for the plant include T. angolensis, T. coccinea Mangenot, T. dubia Hemsl., T. elegans Hemsl., and T. ugandensis Hemsl. It is a eshy subterranean herb growing from an underground tuber. It is a parasitic plant growing on the terminal roots of host plants such as Hevea brasiliensis, Phoenix dactylifera and Theobroma cacao. 1 The owering stem produces a bright red or pink inorescence containing male and female owers. The plant grows in Tropical Africa, from Senegal to Ethiopia, south to Angola, Zambia and Tanzania. It is commonly found in rainforests, gallery forests and adjacent woodland.
1 Commonly known in English as "ground pineapple", it is also known as "kwaebedwaa" in the local Akan language of Ghana.
T. sanguinea is best known for its use in traditional medicine in many African countries. In Ghanaian traditional medicine for instance, this plant is used in treatment of bronchial asthma sometimes for prophylaxis, 2 sexually transmitted diseases and as an aphrodisiac. It is used to treat diarrhoea and worm infestation in Cote d'Ivoire and Congo. It is also mixed with Capsicum to produce a topical cream for treating haemorrhoids and torticollis. It is also used to treat dysentery, sore throat, skin infections, abscesses, dental caries, gingivitis, fever, malaria, heart disease, rickets, and rheumatism. 1, 3, 4 Chemically, an aqueous and hydroalcoholic ower extract of T. sanguinea revealed the presence of alkaloids, catechin tannins, avonoids, saponins, quinones and polyphenols on preliminary screening. 5 Brevifolin carboxylic acid (BCA), 6 gallic acid (GA) 6 and two ellagitannins: thonningianins A (Th A) and Th B 7 are the only four compounds reported to have been isolated from the plant. N'guessan et al. reported that both GA and BCA, isolated from T. sanguinea demonstrated moderate antibacterial activity against Salmonella enteritidis, Salmonella typhimurium, and Salmonella abony in the disc diffusion method, with signicant antioxidant activity in the DPPH radical scavenging activity assay. 6 GA is well known as a potent antioxidant phenolic compound, with numerous biological activities including antitumor, antimicrobial and antimelanogenic. 6 BCA has been shown to inactivate HBsAg and inhibit hepatitis B virus replication and tumour growth. 8 The ellagitannins isolated from the plant also possessed hepatoprotective actions, potent antimicrobial effects 4, 6, 7, 9 and signicant free radical scavenging activity against DPPH by ESR analysis. 7 Th A effectively inhibited of the proliferation of HepG-2 human hepatocellular carcinoma cells by inducing apoptosis. This was observed as an increase in the sub-G1 cell population, DNA fragmentation, and increase in the content of reactive oxygen species. 10 Th A was also shown to be a potent in vitro inhibitor of rat liver crude glutathione S-transferases (GSTs) and hGSTP1-1 activity.
11
Biological study on T. sanguinea plant extracts (in vivo and in vitro assays) indicated the prophylactic potential of the aqueous extract and its n-butanolic fraction in bronchial asthma. The active agents extracted into n-butanol and may be avonoids and/or phenolic in nature. 12 The anticoccidial activity of the extract against Eimeria sp. sporazoites, 13 antibacterial effects against some multidrug resistant strains of Salmonella enterica 16 and their effects on extended spectrum-b-Lactamases (ESBL) producing Escherichia coli and Klebsiella pneumoniae strains 3 have been reported. The signicant antimalarial effects of T. sanguinea root extracts against Plasmodium falciparum (in vitro), 14 Plasmodium berghei and Plasmodium chabaudi (in vivo) 1 have also been reported. The aqueous extract of T. sanguinea exhibited hepatoprotective activity towards a variety of different toxicants including galactosamine, carbon tetrachloride and aatoxin B1. 2, 15 It also suppressed CYP3A2 and CYP1A2 expression at the level of transcription, 16 protects against aa-toxin B1 acute hepatotoxicity in Fischer 344 rats 2 and also inhibits the liver drug metabolising enzymes of rats.
17
The aqueous decoction of T. sanguinea has been used for more than thirty ve years as a mono-herbal product produced by the Centre for Plant medicine Research, AkuapemMampong, Ghana (CPMR) under the registered names CAMPA-T® and NINGER®. Due to the reported clinical effectiveness of these herbal formulations at the CPMR clinic, they have been approved for use as standardised herbal medicines by the Food and Drug Authority. CAMPA-T® and NINGER® are now part of the Essential Herbal Medicines List recommended for use in pilot herbal clinics under the Integrated Herbal Medicine Services Programme in public hospitals. These T. sanguinea-based products are prescribed for the management of arthritic pain, sexual weakness, male and female infertility, dysmenorrhoea, amenorrhoea and uterine broids. Therefore, T. sanguinea is an important medicinal plant that is contributing immensely to public health care in Ghana.
Despite the interesting clinical usage in Ghana, as well as the reported pharmacological activities of the extracts of T. sanguinea, there is no detailed study on the chemical composition of the plant. In this report, we seek to provide a chemical prole for T. sanguinea to better understand these reported pharmacological activities and give credence to its use in traditional medicine.
Experimental

General experimental information
NMR spectra were recorded in chloroform-d, methanol-d 4 and pyridine-d 5 (Nacalai Tesque, Inc., Kyoto, Japan) with Varian Unity Plus 400 spectrometer (Palo Alto, CA, USA) operating at 400 MHz for 1 H and 100 MHz for 13 C, and with a JEOL JNM-AL 300 spectrometer (JEOL Ltd, Tokyo, Japan) at 300 MHz for 1 H NMR. The UV spectra were recorded using a double beam Shimadzu UV-visible spectrophotometer (model UV-1601 PC, Kyoto City, Japan). IR spectra were recorded using a Jasco FT/IR-410 K spectrometer (Jasco Co. Ltd., Tokyo, Japan) with a range of 400-4000 cm
À1
. FAB-MS spectra were recorded on a JMS 700N spectrometer (JEOL Ltd., Tokyo, Japan) in positive ion mode, with glycerol or m-nitrobenzyl alcohol, with or without NaCl, as the matrix. The optical rotation measurements were done using a Jasco P-1020 polarimeter (Jasco Co. Ltd., Tokyo, Japan). Extraction and isolation of compounds were done the following solvents: acetone, acetonitrile, n-butanol, chloroform, ethyl acetate, n-hexane and methanol (Nacalai Tesque, Inc., Kyoto, Japan). Column chromatography (CC) was performed using Sephadex LH-20 (25-100 mm, GE Healthcare UK Ltd., Buckinghamshire HP7 9NA, UK), silica gel Purasil 60Å, 230-400 mesh (Whatman, Sanford, ME, USA) and Cosmosil 140C 18 -PREP silica gel 90Å, 40-63 mesh (Nacalai Tesque, Inc., Kyoto, Japan). TLC was performed on 0.25 mm thick, precoated silica gel 60 F 254 and silica gel RP-18 F 254 plates (Merck, Darmstadt, Germany). Prep. TLC was performed on 2 mm thick PLC silica gel 60 F 254 glass plates (Merck, Darmstadt, Germany). Spots were developed with 5% H 2 SO 4 : MeOH and detected by illumination under a short wavelength UV (254 nm). Analytical HPLC was performed on a Cosmosil 5C 18 -AR-II 4.6 mm Â 250 mm column (Nacalai Tesque, Inc., Kyoto, Japan) with methanol (Nacalai Tesque, Inc., Kyoto, Japan) at a ow rate of 0.8 mL min À1 and Cosmosil-sugar-D 4.6 ID Â 250 mm, 1 mL min À1 , refractive index (RI) detector using 95% acetonitrile.
Preparative HPLC was performed on a Develosil 5C 18 4.6 mm Â 150 mm column (Nacalai Tesque, Inc., Kyoto, Japan) using 100% MeOH as solvent, at a ow rate of 0.5 mL min À1 on a Jasco DG-2080-53 Plus degasser, Jasco PU-2080 Plus pump, Jasco AS-2055 Plus auto sampler, Jasco CO-2065 Plus column oven (maintained at 35 C) and Jasco MD-2018 Plus PDA detector (Jasco Co. Ltd., Tokyo, Japan).
Plant collection and identication
Thonningia sanguinea whole plant was collected by the staff of the Centre for Plant Medicine Research from the eastern region of Ghana in the month of January, 2015 and authenticated by the curator of their herbarium. A voucher specimen with the number CSRPM no. 140 was assigned to the sample.
Extraction and isolation
The whole plant of T. sanguinea was shade-dried for seven days and pulverised. The dried powdered plant material (3.5 kg) was extracted by cold maceration with MeOH (3 Â 10 L for 3 days), followed by MeOH : CHCl 3 (1 : 1; 3 Â 10 L for 3 days). The ltrates were pooled together and concentrated in vacuo using the rotary evaporator. The methanol/chloroform crude extract (423 g) was dissolved in distilled water and serially partitioned between n-hexane, ethyl acetate, n-butanol solvents to obtain the n-hexane (20 g), ethyl acetate (260 g), n-butanol (88 g) and aqueous (30 g) fractions. The n-hexane fraction (20 g) was subjected to silica gel CC (800 g) using n-hexane : EtOAc (9 : 1-1 : 9), CHCl 3 : MeOH (8 : 2-6 : 4) and 80% acetone to give sixteen sub-fractions (H-1-H-16). Fraction H-4 (500 mg) was subjected to repeated silica gel CC using n-hexane : EtOAc (8.5 : 1.5-1 : 1) to afford compound 6 (200 mg). Fraction H-5 (330 mg) was subjected to repeated silica gel CC using CHCl Fraction E-2 (1.08 g) was subjected to silica gel CC (10 g) using n-hexane : EtOAc (8 : 2-2 : 8) to give fourteen subfractions (E-2-1-E-2-14) which afforded compound 8 (100 mg) and 9 (200 mg). Fraction EÀ9 (500 mg) was subjected to silica gel CC (15 g) using CHCl 3 : MeOH (9.9 : 0.1-9.6 : 0.4) to give sixteen sub-fractions (E-9-1-E-9-16). E-9-7 (175 mg) was subjected to repeated silica gel CC (10 g) using n-hexane : EtOAc 
2.3.4
Methanolysis of TSC-1. TSC-1 (5 mg) was heated with 5% HCl in MeOH (0.5 mL) at 70 C for 8 h in a sealed smallvolume vial. The reaction mixture was extracted with nhexane and the extract was concentrated in vacuo to yield a mixture of fatty acid methyl ester (FAME) products. The methanolic layer was neutralized with Ag 2 CO 3 , ltered, and the ltrate was concentrated in vacuo to give a mixture of long chain base (LCB) and methyl glycoside products. The mixture was further evaporated and reacted with acetic anhydride/ pyridine (1 : 1) (0.2 mL) at 70 C for 8 h in a sealed smallvolume vial followed by evaporation in vacuo to dryness. The mixture was separated using preparative TLC to afford the LCB, LCB acetates and LCB glucoacetates. 1 H, 13 C NMR and FAB-MS analyses were performed on the FAMEs and the LCB products.
Methanolysis of TSC-2.
In the same manner as described for TSC-1, TSC-2 (5 mg) was methanolyzed and the reaction mixture was worked up to give the FAMEs, LCB, LCB acetates and LCB glucoacetates. The 1 H, 13 C NMR and FAB-MS analyses were performed on the FAMEs and the LCB products. C for 8 h in a sealed small-volume vial. The reaction mixture was extracted with CHCl 3 to remove the release fatty acid. The methanolic was neutralized with Ag 2 CO 3 to give the methylated sugar followed by HPLC analysis HPLC analysis (Cosmosil-sugar-D, 4.6 ID Â 250 mm, 1 mL min À1 , RI detector, 95% acetonitrile) against standard glucose and galactose. TSC-1 showed a retention time identical to glucose (glucose t R ¼ 14.11 min, galactose t R ¼ 13.27 min). In the same way, the sugar moiety was identied as glucose for TSC-2 and TSS-1. 2.3.11 Determination of the absolute conguration of the glucose moiety in TSC-1 (Tanaka et al. Method). 18 The glycosidic bond in TSC-1 (2 mg, 1.1 Â 10 6 mol) was hydrolyzed by heating in 0.5 M HCl (0.1 mL) and neutralized with Amberlite IRA400. Aer drying in vacuo, the residue was dissolved in pyridine (0.1 mL) containing L-cysteine methyl ester hydrochloride (0.5 mg) and heated at 60 C for 1 h. A 0.1 mL solution of o-tolyl isothiocyanate (0.5 mg) in pyridine was added to the mixture, which was heated at 60 C for 1 h. The reaction mixture was directly analyzed by reversed-phase HPLC. The peaks at 18.68 min which were coincided with the arylisothiocyanate derivative of D-glucose (L-glucose t R ¼ 19.22 min). In the same way as described for TSC-1, the absolute conguration of the glucose moiety (D-form) of TSC-2 (at t R ¼ 18.5 min) and TSS-1 (at t R ¼ 18.7 min) were also determined. See Fig. 1 and 2 ; Spectral data. 
Results and discussion
Chromatographic separation of the n-hexane fraction, from the chloroform/methanol crude extract of T. sanguinea whole plant lead to the isolation of two glucocerebroside molecular species TSC-1 and TSC-2, and one b-sitosteryl-3b-D-glucopyranoside-6 0 -Ofatty acid ester molecular species TSS-1, together with seven known triterpenes:
and betulinic acid 7. Five known lignans: (+)-epipinoresinol 8, (+)-pinoresinol 9, (+)-cycloolivil, 10, (+)-secoisolariciresinol 11 and (+)-isolariciresinol 12 and one known avanone (+)-eriodictyol 13, were also isolated from the ethyl acetate fraction of T. sanguinea whole plant. The known compounds were identied by comparison with authentic samples or reported spectral and physical data. See Fig. 1 and 2 ; Spectral data. To identify the sugar moiety in TSS-1, the methylated sugar moiety in the aqueous layer aer methanolysis was analysed by HPLC against standard sugars (glucose and galactose) and identied as glucose (glucose t R ¼ 14.11 min, galactose t R ¼ 13.27 min). The coupling constant of the anomeric proton at d 
18
The absolute conguration of the sugar moiety was determined by the Tanaka et al. method.
18 Direct HPLC analysis of the reaction mixture of the sugar moiety exhibited a peak at t R ¼ 18.7 min, which were coincided with the aryl-isothiocyanate derivative of D-glucose, conrming the absolute conguration of the sugar moiety (L-glucose t R ¼ 19.22 min). The sphingosine skeleton was characterized by comparison of its 1 H and 13 C NMR spectral data ( Fig. 1 and Table 1 ) with that of known cerebrosides. 27 The relative stereochemistry of the ceramide moiety is presumed to be (2S,3R,4E,2 0 R) since the uration. 27 The analysis of the methylated sugar against standard sugars (glucose and galactose) using HPLC indicated that the sugar moiety in TSC-1 was glucose (glucose t R ¼ 14.11 min, galactose t R ¼ 13.27 min). The coupling constant of the anomeric proton at d 18 The absolute conguration of the sugar moiety was determined using the Tanaka et al.
method.
18 HPLC analysis of the reaction mixture exhibited a peak at t R ¼ 18.68 min, which were coincided with the arylisothiocyanate derivative of D-glucose, conrming the absolute conguration of the sugar moiety (L-glucose t R ¼ 19.22 min).
To determine the length of the FAMEs and LCB in the glucocerebrosides, the methanolysis products of TSC-1 were subjected to 1 H, 13 18 The absolute conguration of the sugar moiety was determined using the Tanaka et al.
18 HPLC analysis of the reaction mixture exhibited a peak at t R ¼ 18.5 min, which were coincided with the arylisothiocyanate derivative of D-glucose, conrmed the absolute conguration of the sugar moiety (L-glucose t R ¼ 19.22 min).
In the positive FAB-MS spectral of TSC-2, a series of molecular ion peaks due to 810, 824, 838, 852, 866 and 880 [M + Na] + were observed. Therefore, TSC-2 is presumed to be a molecular species consisting of a phytosphingosine-type cerebroside possessing mainly a 2-hydroxy fatty acid moiety (normal methyls at d C 13.6) and a b-D-glucopyranose moiety. The core structure of the phytosphingosine skeleton in TSC-2 was characterized by comparison of its 1 H and 13 C NMR spectral data ( Fig. 1 and Table 1 ) with that of known cerebrosides. 28 The relative stereochemistry of the ceramide moiety is presumed to be (2S,3R,4R,2 0 R) since the characteristic 13 phytosphingosines-type glucocerebroside molecular species possessing a 2S,3R,4R,2 0 R conguration.
28
In the FAB-MS analyses of the methanolysis products of TSC-2, the FAME mixture showed molecular ion peaks at 343, respectively. See Fig. 1 and Table 1 .
Discussion
A sphingosine-type (TSC-1) and phytosphingosine-type (TSC-2) cerebrosides, with both containing mainly a 2-hydroxy fatty acids and b-D-glucopyranose moieties were isolated from the nhexane fraction of T. sanguinea in this study. Cerebrosides and ceramides have received a lot of interest in their isolation and characterization due to their signicant biological activities such as immunomodulatory antioxidant, antitumour, antiinammatory and antiviral.
29,30
Seven triterpenes were isolated from the n-hexane fraction of plant 
31,32
Betulinic acid exhibits a variety of biological and medicinal properties such as inhibition of HIV, antibacterial, antimalarial, antiinammatory, antihelmintic, antinociceptive, anti-HSV-1 and anticancer activities.
33
The ve lignans isolated from the ethyl acetate fraction of T. sanguinea: (+)-epipinoresinol 8, (+)-pinoresinol 9, (+)-cycloolivil 10, (+)-secoisolariciresinol 11 and (+)-isolariciresinol 12 are reported to also have antiviral, antifungal, antimicrobial antifeedant and insecticidal properties and are probably related to plant defense against various pathogens and pests. They also have signicant biological activities including antitumour, antiinammatory, immunosuppression, cardiovascular, antioxidant and antiviral.
34
Pinoresinol and secoisolariciresinol are mammalian lignan precursors which are converted into enterodiol (END) and enterolactone (ENL) by the intestinal microora. 22, 35 These enterolignans afford protection against osteoporosis, cardiovascular diseases, liver diseases, hyperlipidemia, breast cancer, colon cancer, prostate cancer and menopausal syndrome. 25, 36, 37 The avanone (+)-eriodictyol 13, also isolated from the ethyl acetate fraction is reported to have signicant antiinammatory, anticancer, neurotrophic, and antioxidant effects. 
Conclusions
In summary, this paper describes the isolation of two glucocerebrosides, TSC-1 and TSC-2, one molecular species TSS-1, seven triterpenes 1-7, ve lignans 8-12, and one avanone 13, from the n-hexane and ethyl acetate fractions of whole plant of T. sanguinea. To the best of our knowledge, all the isolated compounds from T. sanguinea in this study are being reported for the rst time. These compounds have a wide range of biological activities and may act individually or in synergy to produce these biological effects. They may therefore be partly, or wholly responsible for these biological actions, giving credence to the use of T. sanguinea in traditional medicine. Further work to increase the amount of isolated cerebrosides molecular species to determine the double bond location in the long chain bases as well as purify and characterize the individual pure cerebrosides is underway.
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